1-5 of 5
Horst Lindhofer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Induction of Anti-Cancer Effects by Targeting Alloreactive Intentionally Mismatched T Cells and NK Cells to Tumor Cells Using Bi-Specific Trifunctional Antibodies.

Shoshana Morecki, PhD, Horst Lindhofer, PhD, Elena Yacovlev, Yael Gelfand, MSc, Shimon Slavin, MD
Journal: Blood
Blood (2006) 108 (11): 3245.
https://doi.org/10.1182/blood.V108.11.3245.3245
Published: 2006
Journal Articles

Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes

Shoshana Morecki, Horst Lindhofer, Elena Yacovlev, Yael Gelfand, Shimon Slavin
Journal: Blood
Blood (2006) 107 (4): 1564–1569.
https://doi.org/10.1182/blood-2005-07-2738
Published: 2006
Journal Articles

Adoptive Immunotherapy of p53-Mutated B-CLL with a Trifunctional Antibody (Anti-CD3 x Anti-CD20) and Allogeneic Donor Lymphocyte Transfusion.

Raymund Buhmann, MD, Michael Stanglmaier, PhD, Belinda Simoes, MD, Ting Yang, MD, Peter Ruf, PhD, Horst Lindhofer, PhD, Hans-Jochem Kolb, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 4823.
https://doi.org/10.1182/blood.V106.11.4823.4823
Published: 2005
Journal Articles

Impact of the lymphoma idiotype on in vivo tumor protection in a vaccination model based on targeting antigens to antigen-presenting cells

Konrad Kronenberger, Andreas Dieckmann, Michael Selmayr, John Strehl, Ulrich Wahl, Horst Lindhofer, Georg Kraal, Ralph Mocikat
Journal: Blood
Blood (2002) 99 (4): 1327–1331.
https://doi.org/10.1182/blood.V99.4.1327
Published: 2002
Journal Articles

Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody

Peter Ruf, Horst Lindhofer
Journal: Blood
Blood (2001) 98 (8): 2526–2534.
https://doi.org/10.1182/blood.V98.8.2526
Published: 2001